These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16761192)

  • 21. Efficacy of exercise, losartan, enalapril, atenolol and rilmenidine in subjects with blood pressure hyperreactivity at treadmill stress test and left ventricular hypertrophy.
    Avanza AC; Mansur AP; Ramires JA
    J Hum Hypertens; 2009 Apr; 23(4):259-66. PubMed ID: 18946484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rilmenidine in the hypertensive type-2 diabetic: a controlled pilot study versus captopril.
    Bauduceau B; Mayaudon H; Dupuy O
    J Cardiovasc Risk; 2000 Feb; 7(1):57-61. PubMed ID: 10785875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-effect relationship of rilmenidine after chronic administration.
    Luccioni R; Lambert M; Ambrosi P; Scemama M
    Eur J Clin Pharmacol; 1993; 45(2):157-60. PubMed ID: 8223838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of imidazoline receptors and alpha2-adrenoceptors in the rostral ventrolateral medulla to sympathetic baroreflex inhibition by systemic rilmenidine.
    Chan CK; Burke SL; Head GA
    J Hypertens; 2007 Jan; 25(1):147-55. PubMed ID: 17143186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of rilmenidine on tests of autonomic function in humans.
    McKaigue JP; Harron DW
    Clin Pharmacol Ther; 1992 Nov; 52(5):511-7. PubMed ID: 1358495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular and central nervous system effects of rilmenidine (S 3341) in rats.
    Koenig-Berard E; Tierney C; Beau B; Delbarre G; Lhoste F; Labrid C
    Am J Cardiol; 1988 Feb; 61(7):22D-31D. PubMed ID: 2894153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The hypotensive action of rilmenidine is dependent on functional N-methyl-D-aspartate receptor in the rostral ventrolateral medulla of conscious spontaneously hypertensive rats.
    Zhang J; Abdel-Rahman AA
    J Pharmacol Exp Ther; 2002 Oct; 303(1):204-10. PubMed ID: 12235252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiorespiratory responses of Hi Fit and Low Fit subjects to mental challenge during exercise.
    Acevedo EO; Webb HE; Weldy ML; Fabianke EC; Orndorff GR; Starks MA
    Int J Sports Med; 2006 Dec; 27(12):1013-22. PubMed ID: 16612743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of I1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine.
    Szabo B; Urban R
    Arzneimittelforschung; 1997 Sep; 47(9):1009-15. PubMed ID: 9342413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and tolerability of rilmenidine compared with isradipine in hypertensive patients with features of metabolic syndrome.
    Widimský J; Sirotiaková J
    Curr Med Res Opin; 2006 Jul; 22(7):1287-94. PubMed ID: 16834827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rilmenidine: a novel approach to first-line treatment of hypertension.
    Laurent S; Safar M
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):99S-105S. PubMed ID: 1350733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study.
    Sadowski Z; Szwed H; Kuch-Wocial A; Kubasik A; Januszewicz W; Krupa-Wojciechowska B; Polak G; Stejfa M; Dvorak I; Balazovjech I; Dubai G; Simon K
    J Hypertens Suppl; 1998 Aug; 16(3):S55-62. PubMed ID: 9747912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of rilmenidine (hyperium) on lipid balance in hyperlipidemic hypertensive patients. Randomized, controlled, double-blind 8-week study vs. captopril in parallel groups].
    Scemama M; Février B; Beucler I; Dairou F
    Ann Cardiol Angeiol (Paris); 1996 Dec; 45(10):595-601. PubMed ID: 9033699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of rilmenidine therapy and its combination with perindopril on blood pressure and left ventricular hypertrophy in patients with essential hypertension (VERITAS).
    Farsang C; Lengyel M; Borbás S; Zorándi A; Dienes BS;
    Curr Med Res Opin; 2003; 19(3):205-17. PubMed ID: 12803735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamic and electrophysiologic effects of a new alpha 2-adrenoceptor agonist, rilmenidine, for systemic hypertension.
    Zannad F; Aliot E; Florentin J; Saulnier JP; Gilgenkrantz JM
    Am J Cardiol; 1988 Feb; 61(7):67D-71D. PubMed ID: 2894162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of centrally induced ventricular arrhythmias by rilmenidine and idazoxan in rabbits.
    Roegel JC; Yannoulis N; De Jong W; Monassier L; Feldman J; Bousquet P
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):598-605. PubMed ID: 8938658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Site and receptors involved in the sympathoinhibitory actions of rilmenidine.
    Head GA; Burke SL; Chan CK
    J Hypertens Suppl; 1998 Aug; 16(3):S7-12. PubMed ID: 9747904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current data on the pharmacology of rilmenidine].
    Montastruc JL; Macquin-Mavier I; Damase-Michel C; Dard B; Tran MA; Valet P
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():25-9. PubMed ID: 2517006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pretreatment with the dopamine agonist quinpirole inhibits central antihypertensive mechanisms in rats.
    van den Buuse M; Tritton SB
    Clin Exp Pharmacol Physiol; 1997; 24(9-10):661-6. PubMed ID: 9315366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sympathetic responses to stress and rilmenidine in 2K1C rabbits: evidence of enhanced nonvascular effector mechanism.
    Head GA; Burke SL
    Hypertension; 2004 Mar; 43(3):636-42. PubMed ID: 14744928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.